Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
How Is Nneile Nkholise Transforming African Healthcare?
Infrastructure & Management How Is Nneile Nkholise Transforming African Healthcare?

Technological sovereignty allows a continent to prioritize its own health challenges without being at the mercy of global shipping delays or exchange rates. Nneile Nkholise is spearheading a transformative movement in African healthcare by merging mechanical engineering with digital design to

Is Healthcare Governance Keeping Pace With Agentic AI?
Infrastructure & Management Is Healthcare Governance Keeping Pace With Agentic AI?

The rapid shift from static AI models to autonomous, agentic systems has fundamentally altered the clinical landscape, leaving traditional regulatory frameworks struggling to remain relevant in a world where software now makes independent medical decisions. Current healthcare environments are

Quibim Launches AI Breast MRI Tool in the EU and UK
Digital Health Quibim Launches AI Breast MRI Tool in the EU and UK

Quibim's expansion into the breast oncology sector represents a strategic effort to improve patient outcomes by providing more accurate clinical predictions from MRI scans. As of 2026, healthcare providers face a significant challenge with approximately 2.3 million new breast cancer cases

Can AI Safely Manage the Mental Health Crisis?
Digital Health Can AI Safely Manage the Mental Health Crisis?

The tragic suicide of a teenager following interactions with an AI chatbot has accelerated a legal and ethical movement to hold developers accountable for clinical safety. As the demand for mental health services continues to outstrip the available human workforce, an estimated 28% of individuals

Cyberattacks Target 60 Percent of Colombia’s Healthcare Sector
Regulatory & Compliance Cyberattacks Target 60 Percent of Colombia’s Healthcare Sector

Cybercriminals prioritize medical records over financial data because a patient's complete diagnostic history and treatment plan hold immense long-term value on the black market. In Colombia, this predatory focus has reached a critical threshold, with medical institutions now enduring the vast

How Will Bexlutry Change the Treatment of GEP-NETs?
Imaging & Diagnostics How Will Bexlutry Change the Treatment of GEP-NETs?

Targeting somatostatin receptor-positive tumors of the foregut, midgut, and hindgut, Bexlutry utilizes lutetium-177 to deliver localized radiation directly to malignant cells. This recent approval by the U.S. Food and Drug Administration (FDA) represents a significant shift for Curium as it

AI-Powered DEPICTA Framework Enables 87-Second Brain MRI Scan
Digital Health AI-Powered DEPICTA Framework Enables 87-Second Brain MRI Scan

The necessity of general anesthesia for pediatric neuroimaging may soon decrease as acquisition times for diagnostic-grade scans drop below the 100-second mark. This advancement represents a significant shift in the landscape of diagnostic neuroimaging, where the integration of artificial

Law Firm Probes Alleged Medical Department Store Data Breach
Regulatory & Compliance Law Firm Probes Alleged Medical Department Store Data Breach

The reliance on both physical retail stores and an extensive e-commerce platform makes the alleged breach of Medical Department Store particularly concerning for Florida residents. This situation highlights the fragile nature of the supply chain for essential durable medical equipment, where

How Will Apple Watch Series 12 Redefine Health and Privacy?
Digital Health How Will Apple Watch Series 12 Redefine Health and Privacy?

While Apple markets the new S11 chip as a breakthrough in cardiovascular monitoring, experts question if these digital insights truly reflect the actual physiological state of the body. This skepticism comes at a time when the Series 12 represents a transformative moment for wearable technology,

Interim HealthCare Faces Dual Ransomware Claims in 2026
Regulatory & Compliance Interim HealthCare Faces Dual Ransomware Claims in 2026

The simultaneous claims from GENESIS and Anubis suggest that multiple initial access brokers may have sold different entry points into Interim HealthCare’s sprawling network of local offices. This convergence of cybercriminal activity highlights a growing crisis within the home healthcare sector,

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later